These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Hepatoprotective mechanism of silymarin: no evidence for involvement of cytochrome P450 2E1. Miguez MP; Anundi I; Sainz-Pardo LA; Lindros KO Chem Biol Interact; 1994 Apr; 91(1):51-63. PubMed ID: 8194125 [TBL] [Abstract][Full Text] [Related]
26. Relative Bioavailability of Silybin A and Silybin B From 2 Multiconstituent Dietary Supplement Formulations Containing Milk Thistle Extract: A Single-dose Study. Li WY; Yu G; Hogan RM; Mohandas R; Frye RF; Gumpricht E; Markowitz JS Clin Ther; 2018 Jan; 40(1):103-113.e1. PubMed ID: 29273470 [TBL] [Abstract][Full Text] [Related]
27. Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C. Schrieber SJ; Hawke RL; Wen Z; Smith PC; Reddy KR; Wahed AS; Belle SH; Afdhal NH; Navarro VJ; Meyers CM; Doo E; Fried MW Drug Metab Dispos; 2011 Dec; 39(12):2182-90. PubMed ID: 21865319 [TBL] [Abstract][Full Text] [Related]
28. Beneficial Effects of Silymarin After the Discontinuation of CCl4-Induced Liver Fibrosis. Clichici S; Olteanu D; Filip A; Nagy AL; Oros A; Mircea PA J Med Food; 2016 Aug; 19(8):789-97. PubMed ID: 27441792 [TBL] [Abstract][Full Text] [Related]
29. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions. Koltai T; Fliegel L J Evid Based Integr Med; 2022; 27():2515690X211068826. PubMed ID: 35018864 [TBL] [Abstract][Full Text] [Related]
30. Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells. Trappoliere M; Caligiuri A; Schmid M; Bertolani C; Failli P; Vizzutti F; Novo E; di Manzano C; Marra F; Loguercio C; Pinzani M J Hepatol; 2009 Jun; 50(6):1102-11. PubMed ID: 19398228 [TBL] [Abstract][Full Text] [Related]
31. The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes. Albassam AA; Frye RF; Markowitz JS Chem Biol Interact; 2017 Jun; 271():24-29. PubMed ID: 28457856 [TBL] [Abstract][Full Text] [Related]
32. Antiviral activity of silymarin against Mayaro virus and protective effect in virus-induced oxidative stress. Camini FC; da Silva TF; da Silva Caetano CC; Almeida LT; Ferraz AC; Alves Vitoreti VM; de Mello Silva B; de Queiroz Silva S; de Magalhães JC; de Brito Magalhães CL Antiviral Res; 2018 Oct; 158():8-12. PubMed ID: 30076863 [TBL] [Abstract][Full Text] [Related]
33. A comparison of hepatoprotective activity of Bacoside to Silymarin treatment against a combined Isoniazid and Rifampin-induced hepatotoxicity in female Wistar rats. Sabina EP; Peter S J; S P; Geetha A J Histotechnol; 2019 Sep; 42(3):128-136. PubMed ID: 31379302 [TBL] [Abstract][Full Text] [Related]
34. Effect of silybin on phorbol myristate actetate-induced protein kinase C translocation, NADPH oxidase activity and apoptosis in human neutrophils. Varga Z; Ujhelyi L; Kiss A; Balla J; Czompa A; Antus S Phytomedicine; 2004 Feb; 11(2-3):206-12. PubMed ID: 15070174 [TBL] [Abstract][Full Text] [Related]
36. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review. Soleimani V; Delghandi PS; Moallem SA; Karimi G Phytother Res; 2019 Jun; 33(6):1627-1638. PubMed ID: 31069872 [TBL] [Abstract][Full Text] [Related]
37. Recent advances in the nanotechnology-based drug delivery of Silybin. Wang Y; Zhang L; Wang Q; Zhang D J Biomed Nanotechnol; 2014 Apr; 10(4):543-58. PubMed ID: 24734507 [TBL] [Abstract][Full Text] [Related]
38. Curcumin, Silybin Phytosome(®) and α-R-Lipoic Acid Mitigate Chronic Hepatitis in Rat by Inhibiting Oxidative Stress and Inflammatory Cytokines Production. Ali SO; Darwish HA; Ismail NA Basic Clin Pharmacol Toxicol; 2016 May; 118(5):369-80. PubMed ID: 26457982 [TBL] [Abstract][Full Text] [Related]
39. Silymarin: a review of its clinical properties in the management of hepatic disorders. Wellington K; Jarvis B BioDrugs; 2001; 15(7):465-89. PubMed ID: 11520257 [TBL] [Abstract][Full Text] [Related]
40. New C-23 modified of silybin and 2,3-dehydrosilybin: synthesis and preliminary evaluation of antioxidant properties. Zarrelli A; Sgambato A; Petito V; De Napoli L; Previtera L; Di Fabio G Bioorg Med Chem Lett; 2011 Aug; 21(15):4389-92. PubMed ID: 21737270 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]